The Effect of Motilin on the Frequency and Amount of Food Intake

Sponsor
Universitaire Ziekenhuizen Leuven (Other)
Overall Status
Unknown status
CT.gov ID
NCT03024879
Collaborator
(none)
15
2

Study Details

Study Description

Brief Summary

In this study, the investigators aimed at evaluating the role of motilin in the regulation of food intake. Motilin, a gastrointestinal hormone, is a hunger signal in healthy volunteers and is significantly increased in obese patients. Its role in food intake regulation might contribute to the pathogenesis of obesity.

Condition or Disease Intervention/Treatment Phase
Phase 4

Study Design

Study Type:
Interventional
Anticipated Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Basic Science
Official Title:
Influence of Erythromycin on ad Libitum Food Intake and the Evaluation of Motilin in Food Timing in Healthy Volunteers and Patients
Study Start Date :
Mar 1, 2014
Anticipated Primary Completion Date :
Mar 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Erythromycin

40 mg of erythromycin will be administered intravenously over a period of 20 min in a saline solution of 100 ml

Drug: Erythromycin

Placebo Comparator: Placebo

a saline solution of 100 ml will be administered intravenously over a period of 20 min

Drug: Saline

Outcome Measures

Primary Outcome Measures

  1. Change in food intake, assessed by caloric intake, after intravenous administration of erythromycin compared to placebo [Caloric intake will be assessed 1 hour after the start of infusion and the start of ad libitum food intake]

Secondary Outcome Measures

  1. Frequency of food intake correlated with motilin plasma levels [Assessment will be done over a period of 5 hours]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • BMI < 30 kg/m² for lean volunteers

  • BMI > 30 kg/m² for obese volunteers

  • Subject is capable and willing to give informed consent

  • Female volunteers of child bearing potential must use oral, injected or implanted hormonal methods of contraception

Exclusion Criteria:
  • Female volunteer is pregnant or breastfeeding

  • GI diseases, major abdominal surgery

  • Major psychiatric illnesses

  • Volunteers that use drugs affecting the GI tract or the central nervous system

  • Volunteers suffering from endocrine diseases such as diabetes, Cushing's disease, Addison's disease, hypothalamic tumor

  • Volunteers that have undergone surgical procedure for weight loss

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Universitaire Ziekenhuizen Leuven

Investigators

  • Principal Investigator: Jan Tack, Prof, Universitaire Ziekenhuizen Leuven

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier:
NCT03024879
Other Study ID Numbers:
  • MotilinAndFoodIntake
First Posted:
Jan 19, 2017
Last Update Posted:
Jan 19, 2017
Last Verified:
Jan 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Universitaire Ziekenhuizen Leuven
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 19, 2017